Topical vitamin D3 derivatives impair the epidermal permeability barrier in normal mouse skin

Dermatology

Volumn 194, Issue 2, 1997, Pages 151-156

  von Breriken, S ^a   Jensen, J M ^a   Fartasch, M ^b   Proksch, E ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Epidermal DNA synthesis; Permeability barrier; Transcutaneous water loss; Vitamin D3 derivatives

Indexed keywords

CALCIPOTRIOL; COLECALCIFEROL; 1 ALPHA,24 DIHYDROXYVITAMIN D3; 1 ALPHA,24-DIHYDROXYVITAMIN D3; CALCITRIOL; DERMATOLOGICAL AGENT; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE; KERATIN; PROPANOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ELECTRON MICROSCOPY; KERATINIZATION; MALE; MICROSCOPY; MOUSE; NONHUMAN; NUDE MOUSE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PSORIASIS; SKIN PERMEABILITY; SKIN WATER LOSS; TOPICAL DRUG ADMINISTRATION; WATER LOSS; ANIMAL; CELL DIVISION; DRUG EFFECT; EPIDERMIS; GROWTH, DEVELOPMENT AND AGING; HAIRLESS MOUSE; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; OINTMENT; PERMEABILITY; SKIN; THERMOREGULATION; TIME; VASCULARIZATION;

1-PROPANOL; ADMINISTRATION, CUTANEOUS; ANIMALS; CALCITRIOL; CELL DIVISION; CHOLECALCIFEROL; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; EPIDERMIS; KERATINS; MALE; MICE; MICE, INBRED HRS; MICROSCOPY, ELECTRON; OINTMENTS; PERMEABILITY; PSORIASIS; SKIN; TIME FACTORS; WATER LOSS, INSENSIBLE;

EID: 0030611174     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246085     Document Type: Article

References (27)

1. Morimoto S. Yoshikawa K. Kozuka T: An open study of vitamin D, treatment in psoriasis vulgaris. BrJ Dermatol 1986:115:421-129.
2. Kalo T. Rokugo M. Terui T. Tagami H: Successful treatment of psoriasis with topical application of active vitamin D, analogue. I alpha. 24-dihydroxycholecalciferol. BrJ Dermatol 1986:115:431-433.
3. Smith EL. Pincus SH, Donovan L. Holick MF: A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 1988: 19:516-526.
4. dc Mare S, de Jong EMGJ. van de Kerkhof PCM: DNA content and K.8.12 binding of the psoriatic lesion during treatment with the vitamin D, analogue MC903 and betamethasone. BrJ Dermatol 1990;123:291-295.
5. Kragballe K. Gjertzen BT. de Hoop D. Double-blind, right/left comparison of calci-potriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991:337: 193-196.
6. Gerritsen MJP. Boezeman JBM. vanvlijmen-Willems MJJ. vande Kerkhof PCM: The effect of tacalcitol 11,24(OH), D,] on cutaneous inflammation, epidermal proliferation and ke-ratinization in psoriasis: A placebo-controlled, double-blind study. BrJ Dermatol 1994:131: 57-63.
7. Kragballe K: Treatment of psoriasis with cal-cipotriol and other vitamin D analogues. J Am Acad Dermatol 1992:27:1001-1008.
8. Langner A. Verjans H. Stapdr V. Mol M. Fraezykowska M: Topical calcitriol in the treatment of chronic plaque psoriasis: A double-blind study. Br J Dermatol 1993:128: 566-571.
9. van de Kerkhof PCM: Vitamin D, und seine Analoga in der Dermatologie. Z Hautkr 1994:69:219-226.
10. Murdoch D. Clissold SP: Calcipotriol A: Review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 1992:43:415-429.
11. Lützow-Holm C. Huitfeld H. Brandtzaeg P. Clausen OPF: 1,25-Dihydroxy vitamin D, and the vitamin D analogue Kll 1060 induce hyperproliferation in normal mouse epidermis. J Invest Dermatol 1992:98:525A.
12. Thieroff-Ekerdt R. Gerhard D. Krause A. Wiesinger H: I alpha,25-dihydroxy vitamin D induces epidermal hyperproliferation in normal mouse skin. J Invest Dermatol 1993:100: 521A.
13. Thieroff-Ekerdt R. Gerhard D. Hartung A. Krause A. Wicsingcr H: Erythema induction by calcipotriol: A vitamin D receptor-mediated effect? J Invest Dermatol 1994:286:159A.
14. Proksch E. Feingold KR. Mao-Qiang M. Elias PM: Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991;87:1668-1673.
15. Wolff MH. Gnas W: lmmunocytochemical detection of in vitro incorporated 5-bromodeoxy-uridine in paraffin sections of human skin. Arch Dermatol Res 1989:281:209-212.
16. Hashimoto-Kumasaka K. Takahashi K. Tagami H: Electrical measurement of the water content of the stratum corneum in vivo and in vitro under various conditions: Comparison between skin surface hygrometer and corneo-meter in evaluation of the skin surface hydration slate. Acta Derm Venereol (Stockh) 1993; 73:335-339.
17. Gniadecki R. Gniadecka M. Serup J: The effects of KH 1060. a potent 20-epi analogue of the vitamin D, hormone, on hairless mouse skin in vivo. BrJ Dermatol 1995:132:841-852.
18. Lützow-Holm C, Heyden A. Huitfeld HS. Brandtzaeg P. Clausen OPF: Topical application of calcitriol alters expression of filaggrin but not keratin K1 in mouse epidermis. Arch Dermatol Res 1995;287:480-487.
19. Proksch E. Elias PM. Feingold KR: Regulation of 3-hydroxy-3-methylglutaryl-coenz, yme A reductase activity in murine epidermis. J Clin Invest 1990:85:874-882.
20. Ekanayake-Mudiyanselage S. Proksch E: Influence of permeability barrier disruption and artificial barrier repair on epidermal differentiation. J Invest Dermatol 1996;106:837A.
21. Kragballe K: Vitamin D, and skin diseases. Arch Dermatol Res 1992;284(suppl): S30-S36.
22. Biklc DD. Pillai S: Vitamin D. calcium and epidermal differentiation. Endocr Rev 1993:14: 3-19.
23. Bittiner B. Blechen SS. MacNeil S: lalpha. 25(OH), vitamin D, increases intracellular calcium in human keratinocytes. Br J Dermatol 1991:124:230-235.
24. Chen TC. Persons K. Lin W-W. Chen ML. Holick MF: The antiproliferative and differen-tiative activities of 1.25-dihydroxy vitamin D. are potentiated by epidermal grow th factor and attenuated by insulin in cultured human keratinocytes. J Invest Dermatol 1995:104:113-117.
25. Geilen CC. Beklas M. Wieder T. Orfanos CE: The vitamin D, analogue, calcipotriol. induces sphingomyelin hydrolysis in human keratinocytes. FEBS Lett 1996:378:88-92.
26. Bissonnette M. Wali RK. Hartmann SC. Niedziela SM. Roy HK. Tien X-Y. Sitrin MD. Brasitus TA: 1,25-Dihydroxy vitamin D, and 12-O-teiradecanoyl phorbol 13-acetate cause differential activation of CA-*-dependent and Ca-'Mndcpcndcnt isoforms of protein kinase C in rat colonocytes. J Clin Invest 1995:95: 2215-2221.
27. Prüfer K. Jirikowski GF: Liposomal incorporation changes the effect of 1,25-dihydroxyvita-min D, on the phospholipase C signal transduction pathway and the eicosanoid cascade on keratinocytes in vitro. Biochem Pharmacol 1996:51:247-252